Cocrystal Pharma Inc
COCP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.17M
Close$
$0.49
53.9% downside
Current Fair Value
53.9% downsideOvervalued by 53.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $19.17 Million |
|---|---|
| Enterprise Value | $18.34 Million |
| Earnings per Share | $-0.78 |
| Beta | 1.48 |
| Outstanding Shares | 13,788,000 |
Return
| Return on Equity | -951.92% |
|---|---|
| Return on Assets | -213.77% |
| Return on Invested Capital | -498.92% |
Valuation & Multiples
| P/E Ratio | -1.24 |
|---|---|
| PEG | -2.3 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 174.66 |
| Enterprise Value to EBIT | -1.81 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 1.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.17
Consensus analyst estimateRevenue Estimate
$50,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.17
Consensus analyst estimateRevenue Estimate
$105,000
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 8.06% |
|---|---|
| Total Invested | $481▼ 99.96% |
| Investors Holding | 1▼ 25.00% |
About Cocrystal Pharma Inc
CEO: Gary Wilcox
